Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
Iberdomide + Belantamab Mafodotin + Dexamethasone for Multiple Myeloma
Recruiting1 awardPhase 1 & 2
Ames, Iowa
This trial investigates the safety and effectiveness of using a combination of iberdomide, belantamab mafodotin, and dexamethasone to treat patients with multiple myel
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service